Peer Review History
| Original SubmissionMarch 4, 2020 |
|---|
|
PONE-D-20-06323 A qualitative exploration of clinicians´ strategies to communicate risks to patients in the complex reality of clinical practice PLOS ONE Dear Dr Richter, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. We would appreciate receiving your revised manuscript by 11 June 2020. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols Please include the following items when submitting your revised manuscript:
Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. We look forward to receiving your revised manuscript. Kind regards, Andrew Soundy Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf 2. Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified how verbal consent was documented and witnessed. Additional Editor Comments (if provided): Mention and make sure you adhere to a qualitative framework and mention which one e.g., O’Brien et al., 2014 or Tong et al., 2007 and include in a supplementary file Give detail in supplementary file of any changes to semi structured interview after piloting Give examples of the analysis within an audit trail - so examples of each stage so the reader could take the data and follow through - or replicate the stages - no need for full interview manuscripts just examples that show clearly the steps Identify the ontological position of your selected methodology too please Make sure the issues of sample size are considered and fit with your pragmatic position Check if member checking and triangulation fits with your paradigmatic position and please reference this for the reader so I can check this. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: N/A ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Thank you for the opportunity to review this article, which examines experienced clinicians’ strategies for communicating risk in the context of their clinical practice. I read the article with interest: the authors have managed to present the at times complex literature on risk communication in a transparent way (Figure 1) and adopt a design that successfully bridges theory and clinical practice. The findings point to the importance of contextual factors in risk communication and relatedly the discursive context of shared decision-making conversations, factors which the authors point out are missing from existing risk communication guidelines and literature. The article is very well-written throughout, with a clarity that stems from the writing but also from the supporting figures and well-selected quotes. As the authors argue, the findings have practical implications for advanced communication skills for junior doctors/ trainees. My comments are mainly to do with points of clarification and suggestions, including phrasing suggestions, which are outlined below. Abstract - Suggest there is a word order issue: ‘but fan fear of anxiety’ should be ‘but fear fanning anxiety’. Background - Lines 76-77: the choice of ‘manipulation’ is quite strong and implies a negative intention on the behalf of the clinician to my reading. The data (quotes) however from the participants suggest the choice of framing is considered and patient oriented. Alternatively, ‘Choice of framing can influence’ etc. - Communicating risk to patients in daily clinical practice (lines 93-101, p4): most of the references in this section are from general practice, so it was unclear to me whether ‘daily clinical practice’ referred to primary care or was intended to be more generic. However, a major finding was the importance of clinical context (the disease setting as well as patient characteristics), yet this isn’t foreshadowed in this introductory section. Perhaps continue to build the research gap after line 97 by giving examples of the likely risk communication settings/ challenges for different clinical contexts, in which the ‘daily clinical practice’ will look very different. - Lines 103 104 p.4, read like the first line of the conclusion. Instead – the aim is to … - I suggest the phrase ‘young doctors’ is replaced by junior doctors or simply ‘trainees.’ They are not always ‘young’ by the time they finish their training! - The introduction is very well written, providing a strong rationale for the research. Methods The study design is thoughtful, fit for purpose and creative. Figure 1 is likely to be useful for educators (as are the findings). I also like the transparency of research practices e.g. in lines 155-156, p6 Data analysis: I would like some clarification on the inductive analysis. Lines 163, page 6 mentions themes but the reference, 50, is to qualitative content analysis rather than thematic analysis. I suggest the analysis was content analysis. The section on techniques to enhance trustworthiness is exemplary because it covers a range of processes in the methods, not just analysis. For the analysis, however, the data analysis sentence p. 177 refers to going back to the interviews. There is little on how the transcripts were coded for the inductive component -here and in the preceding data analysis section. This could be elaborated. Results Table 2 is illuminating about the types of risks communication and the contexts in which they occur. Figure 2 is also instructive, and I can see the applications of these tables and figures to teaching. The quotes are well chosen to support the construct presented. Pl0, line 238. Should it read So […] to too quickly going through.. evaluative too, or to? Both work but different meanings. The finding in line 260 p. 11 is important and is supported by the quotes; I don’t think this findings is sufficiently reflected in the abstract ie noted the ‘goal oriented’ nature of the clinician’s communication is really part of the SDM (informed by the patient’s goal) and not a paternalistic, clinician centred goal. Discussion P. 19 for clarification: in the recommendation for practice “therefore, an holistic, context-specific and goal-directed approach…” do the authors mean that the approach to risk communication should be sensitive to context rather than context specific, where context specific refers to teaching risk communication approaches tailored to a particular clinical discipline? I think the message is the former rather than the latter as it is the principle. It might also be worth clarifying here and in the conclusion (line 546) that the clinician’s communication goals are informed by the goals of the patient. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Robyn Woodward-Kron [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
A qualitative exploration of clinicians´ strategies to communicate risks to patients in the complex reality of clinical practice PONE-D-20-06323R1 Dear Dr. Richter, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Andrew Soundy Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: N/A ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: (No Response) ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Robyn Woodward-Kron |
| Formally Accepted |
|
PONE-D-20-06323R1 A qualitative exploration of clinicians’ strategies to communicate risks to patients in the complex reality of clinical practice Dear Dr. Richter: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Andrew Soundy Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .